Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPREVENT EquationsPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

CRUSADE Bleeding Score

CRUSADE Bleeding Score: Estimates in-hospital major bleeding risk in NSTEMI/UA. Endorsed by ACC/AHA guidelines.

Female Sex
Signs of CHF at presentation
Prior Vascular Disease
Diabetes Mellitus
Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

When to Use

Patients presenting with Non-ST-Elevation Myocardial Infarction (NSTEMI) or Unstable Angina (UA)
To stratify the risk of major, in-hospital bleeding prior to initiating antithrombotic therapy and making decisions regarding invasive management

Do Not Use If

Not primarily validated for STEMI patients or for outpatients. The score is specifically for in-hospital bleeding in the NSTEMI/UA population.

How it Works

Scoring Logic

The CRUSADE score is a weighted algorithm using 8 baseline variables (4 continuous, 4 categorical) routinely collected at presentation. Points are assigned non-linearly based on the independent predictive power of each variable for major bleeding.

Variables

01
Baseline Hematocrit (%): Severe anemia significantly increases bleeding risk points (<31.5% = 44 pts).
02
Creatinine Clearance (mL/min): Severe renal impairment drives risk (≤15 mL/min = 39 pts).
03
Heart Rate (bpm): Tachycardia correlates with worse outcomes.
04
Systolic BP (mmHg): Both extremes (≤90 and ≥201) carry points.
05
Female Sex: Carries 8 points.
06
Signs of CHF at presentation: Carries 7 points.
07
Prior Vascular disease and Diabetes mellitus: Carry 6 points each.

Risk Categories

01
≤20: Very Low Risk (3.1%)
02
21-30: Low Risk (5.5%)
03
31-40: Moderate Risk (8.6%)
04
41-50: High Risk (11.9%)
05
>50: Very High Risk (19.5%)

Clinical Pearls

Interpretation in Practice

A high CRUSADE score should NOT automatically preclude a patient from receiving life-saving evidence-based therapies (e.g., dual antiplatelet therapy, anticoagulation, early invasive strategy) if they are also at high ischemic risk (e.g., by GRACE score). Instead, the score should prompt careful dosing, vigilance, and strategies to mitigate bleeding.

Mitigating Strategies

Dose adjustment of antithrombotics based on renal function and weight
Choice of anticoagulation (e.g., preferring fondaparinux or bivalirudin over unfractionated heparin in certain settings depending on local protocols)
Preferential use of radial rather than femoral arterial access for angiography/PCI
Routine use of proton-pump inhibitors (PPIs) in patients at high risk of GI bleed

The Evidence

Derivation Study

Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score.

Subherwal S et al. • Circulation.. 2009;119(14):1873-1882. Derived from a large registry of 71,277 patients.

Next Steps

Complementary Calculators

GRACE Score
TIMI Risk Score for UA/NSTEMI
HAS-BLED Score
Cockcroft-Gault CrCl

Last Comprehensive Review: 2026-07-17

Recent Journal Updates

JAMAJul 21, 2026
Correction to Primary Composite Outcome in a Trial of Transfusion Strategy

Clinical Context

We think this has broad domain relevance to CRUSADE Bleeding Score.

WHO NewsJul 20, 2026
Road deaths fall by 21% globally but stronger action is needed to save lives

Clinical Context

We think this has broad domain relevance to CRUSADE Bleeding Score.

British J HaematologyJul 17, 2026
In a nutshell: Explaining joint and muscle bleeding in individuals with haemophilia A and B

Clinical Context

We think this might be relevant to the clinical guidance for CRUSADE Bleeding Score.